HIPAA-compliant · Same-day admissions available
Learn the signs of pregabalin misuse, dependence, and withdrawal, why mixing Lyrica with other drugs can raise risks, and when to seek professional help safely.
New Hope Health
Editorial Team
Pregabalin is prescribed for several medical conditions, but growing attention around pregabalin misuse and pregabalin abuse has raised questions about Lyrica addiction, drug dependence, and its use as a psychoactive substance. For patients and families in East Tennessee, understanding how this controlled drug fits into broader drug abuse and substance abuse concerns can make it easier to recognize when use may require a closer look. This guide examines current evidence on pregabalin and gabapentin, Lyrica CR, CNS drugs, drug interactions, physical symptoms, and the questions researchers continue to study.
Pregabalin, sold under the brand name Lyrica, is a prescription medication that affects certain nerve signals in the central nervous system. Doctors commonly prescribe pregabalin to treat neuropathic pain caused by conditions such as diabetic nerve damage and spinal cord injury, as well as fibromyalgia and certain types of seizures.
It can help reduce nerve pain and seizure activity when taken as directed. Pregabalin is a Schedule V controlled substance in the United States because it has some potential for misuse and dependence. Taking higher doses, using it more often than prescribed, or combining it with other substances can increase the risk of side effects, physical dependence, and withdrawal symptoms.
Pregabalin has several approved medical uses and can provide significant benefits when taken as prescribed. It is used to manage neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury, and it is also prescribed for fibromyalgia and as an additional treatment for certain seizures.
Pregabalin works by reducing the release of specific neurotransmitters involved in pain signaling and abnormal nerve activity. Benefits can include reduced nerve pain, improved physical functioning, fewer seizure symptoms, and better symptom control for people with qualifying conditions.
Pregabalin misuse occurs when someone takes Lyrica differently than prescribed, uses someone else's medication, takes larger or more frequent doses, or uses it for effects such as relaxation, euphoria, or its relaxing effects. Misuse can increase the risk of tolerance, physical dependence, withdrawal, and other health problems, and some people may take more over time to get the same effect.
Lyrica is a Schedule V controlled substance in the United States because pregabalin has recognized misuse and dependence potential. Risk can be higher among people who misuse opioids or other substances, especially in an opioid dependent individual or when pregabalin is combined with central nervous system depressants.
Warning signs may include taking pregabalin differently than prescribed, seeking early refills, visiting multiple providers, hiding use, or continuing despite health, financial, work, or relationship problems. Strong cravings, unsuccessful attempts to stop, and prioritizing pregabalin over responsibilities may also indicate addiction, though physical dependence alone does not mean addiction.
Behavioral changes may include taking pregabalin differently than prescribed, repeatedly requesting early refills, visiting multiple providers, or spending significant time obtaining or using the medication. A person may also become secretive about their use or continue taking pregabalin despite health, financial, work, or relationship problems.
Other warning signs can include unsuccessful attempts to reduce use, strong cravings, and prioritizing pregabalin over responsibilities or activities. Physical dependence alone does not necessarily mean a person has an addiction, so a professional assessment is important.
Pregabalin misuse can affect concentration, memory, coordination, energy, and judgment. These effects may contribute to missed work, declining performance, difficulty completing daily responsibilities, unsafe driving, or problems at school.
Continued misuse can also strain relationships as drug use becomes harder to control or conceal. Financial problems, isolation, conflict with family members, and reduced interest in usual activities can develop as substance use becomes a larger part of daily life.
A healthcare professional can assess pregabalin use by reviewing dosage patterns, prescriptions, withdrawal symptoms, tolerance, cravings, other substance use, the effects of pregabalin on daily functioning, and the patient's potential risks for misuse and dependence. The assessment may also include medical history, prior substance-use history for those at high risk, current medications, physical health, and mental health symptoms.
Clinicians can determine whether a person's symptoms meet criteria for a substance use disorder and identify co-occurring conditions that may affect treatment. Physical dependence and addiction are different, so the assessment considers the overall pattern of use rather than one symptom alone.
Pregabalin misuse is more common among people with opioid or polysubstance use, with reports increasing from 2004 to 2014. Medical sciences research and systematic review update findings in Drug Safety (Drug Saf), CNS Neuroscience & Therapeutics (CNS Neurosci Ther), and Indian Journal of Psychiatry (Ind Psychiatry) examine dependence, substance P, the “new Valium” comparison, financial support, financial constraints, Morrison MD, and misuse patterns in other countries.
Pregabalin’s rapid absorption as a gabapentinoid used for neuropathic pain and anxiety disorders may also contribute to misuse concerns.
Tolerance can develop when the body becomes accustomed to pregabalin, while regular use can lead to physical dependence. Stopping suddenly after dependence develops can cause withdrawal, so a healthcare provider may recommend gradually reducing the dose.
Symptoms may begin within a day or two after stopping and can include:
Acute withdrawal may last several days to a week, with longer symptoms depending on dose and use. Pregabalin withdrawal can cause anxiety, depression, hallucinations, and severe seizures, while benzodiazepines or venlafaxine may sometimes support treatment.
Pregabalin can increase sedation and breathing risks, especially when combined with other central nervous system depressants. Higher-risk combinations include:
Pregabalin misuse is particularly concerning when opioids or multiple substances are involved. Some people combine pregabalin with opioids to increase sedation or other drug effects, which can increase the risk of respiratory depression and overdose.
Polysubstance use may involve pregabalin alongside opioids, alcohol, benzodiazepines, stimulants, or other prescription medications. Treatment should identify all substances being used rather than addressing pregabalin alone.
Pregabalin should generally not be stopped suddenly after regular use without medical guidance. In some cases, medical detox also uses supportive medications under clinical supervision to alleviate withdrawal symptoms.
Withdrawal management may involve gradually reducing the dose, monitoring symptoms, managing complications, and treating other substance use or health conditions. The appropriate level of care depends on the person's dose, duration of use, withdrawal history, other substances used, and physical and mental health. People with severe symptoms or significant polysubstance use may require a higher level of medical support.
Pregabalin misuse can occur alongside mental health conditions, and some people may misuse the medication while trying to manage untreated symptoms; an allergic reaction is also a serious concern that may need prompt medical attention. Common co-occurring concerns can include:
Addressing substance use and mental health symptoms together can help clinicians identify triggers and develop an appropriate treatment plan.
Risk factors can include a history of substance use disorder, opioid misuse, polysubstance use, taking higher doses than prescribed, and using pregabalin without medical supervision. Untreated pain, anxiety, sleep problems, and other mental health symptoms may also contribute to patterns of misuse.
A risk factor does not mean someone will develop an addiction. Healthcare providers consider the person's overall pattern of use, health history, symptoms, and daily functioning.
Research in Drug Safety, CNS Neuroscience & Therapeutics, and Indian Journal of Psychiatry suggests a history of drug misuse may increase the risk of pregabalin misuse.
Residential treatment provides structured care in a live-in setting and may be appropriate for people with severe substance use, repeated relapse, unstable living conditions, or significant co-occurring disorders. It provides greater daily structure and separation from environments associated with substance use.
Outpatient treatment allows people to live at home while attending scheduled treatment sessions. Depending on clinical needs, care may include standard outpatient treatment, an intensive outpatient program (IOP), or a partial hospitalization program (PHP).
Help may be needed when pregabalin use becomes difficult to control, doses increase, withdrawal develops, or use affects health, work, relationships, or daily life. Severe breathing problems, seizures, loss of consciousness, or a suspected overdose require immediate emergency care.
Identifies substance use, withdrawal risks, and treatment needs.
Helps reduce and monitor withdrawal symptoms.
Provides structured live-in addiction treatment.
PHP provides intensive daytime treatment without an overnight stay.
IOP provides structured treatment several days per week.
Offers flexible therapy and ongoing support.
Helps change behaviors and thought patterns linked to substance use.
Dual Diagnosis Treatment addresses addiction and mental health disorders together.
Builds skills for managing cravings and triggers.
Many insurance plans provide benefits for substance use and mental health treatment. Coverage may include assessments, withdrawal management, residential care, PHP, IOP, outpatient therapy, and mental health services, depending on the plan and medical necessity.
Pregabalin misuse can lead to drug dependence, physical withdrawal symptoms, and pregabalin withdrawal, especially among patients with a prior history of substance abuse or drug addiction. Current evidence and systematic review findings continue to examine Lyrica addiction, the exact mechanism, dose range, drug interactions, dopamine release, excitatory neurotransmitters, and deaths linked to abuse of pregabalin.
A psychiatric assessment can also identify anxiety symptoms, panic attacks, difficulty sleeping, suicidal thoughts, and other concerns linked to psychoactive drugs and CNS drugs. Further research is needed to address misuse related unanswered questions and improve treatment for patients, especially those with opioid dependence or polysubstance use.
At New Hope Healthcare, as an in-network proccvider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial.
Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being.
Effective medication management is a crucial part of the treatment process to ensure safety and success.
Give us a call at 866-799-0806.
Yes. Pregabalin misuse can lead to tolerance, physical dependence, withdrawal, and problematic patterns of use, especially when taken differently than prescribed.
Signs may include taking larger doses, using pregabalin without a prescription, seeking early refills, cravings, sedation, and continuing use despite problems.
Stopping pregabalin after regular use can cause withdrawal symptoms. Medical guidance may help reduce withdrawal risks and manage symptoms safely.
Some people misuse pregabalin for its calming, sedating, or euphoric effects or combine it with other substances to change their effects.
Yes. Combining pregabalin with opioids, alcohol, or other central nervous system depressants can increase sedation and breathing-related risks.
Treatment may include medical assessment, withdrawal management, behavioral therapy, relapse prevention, and treatment for co-occurring substance use or mental health disorders.
Pregabalin is prescribed for several medical conditions, but growing attention around pregabalin misuse and pregabalin abuse has raised questions about Lyrica addiction, drug dependence, and its use as a psychoactive substance. For patients and families in East Tennessee, understanding how this controlled drug fits into broader drug abuse and substance abuse concerns can make it easier to recognize when use may require a closer look. This guide examines current evidence on pregabalin and gabapentin, Lyrica CR, CNS drugs, drug interactions, physical symptoms, and the questions researchers continue to study.
Pregabalin, sold under the brand name Lyrica, is a prescription medication that affects certain nerve signals in the central nervous system. Doctors commonly prescribe pregabalin to treat neuropathic pain caused by conditions such as diabetic nerve damage and spinal cord injury, as well as fibromyalgia and certain types of seizures.
It can help reduce nerve pain and seizure activity when taken as directed. Pregabalin is a Schedule V controlled substance in the United States because it has some potential for misuse and dependence. Taking higher doses, using it more often than prescribed, or combining it with other substances can increase the risk of side effects, physical dependence, and withdrawal symptoms.
Pregabalin has several approved medical uses and can provide significant benefits when taken as prescribed. It is used to manage neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury, and it is also prescribed for fibromyalgia and as an additional treatment for certain seizures.
Pregabalin works by reducing the release of specific neurotransmitters involved in pain signaling and abnormal nerve activity. Benefits can include reduced nerve pain, improved physical functioning, fewer seizure symptoms, and better symptom control for people with qualifying conditions.
Pregabalin misuse occurs when someone takes Lyrica differently than prescribed, uses someone else's medication, takes larger or more frequent doses, or uses it for effects such as relaxation, euphoria, or its relaxing effects. Misuse can increase the risk of tolerance, physical dependence, withdrawal, and other health problems, and some people may take more over time to get the same effect.
Lyrica is a Schedule V controlled substance in the United States because pregabalin has recognized misuse and dependence potential. Risk can be higher among people who misuse opioids or other substances, especially in an opioid dependent individual or when pregabalin is combined with central nervous system depressants.
Warning signs may include taking pregabalin differently than prescribed, seeking early refills, visiting multiple providers, hiding use, or continuing despite health, financial, work, or relationship problems. Strong cravings, unsuccessful attempts to stop, and prioritizing pregabalin over responsibilities may also indicate addiction, though physical dependence alone does not mean addiction.
Behavioral changes may include taking pregabalin differently than prescribed, repeatedly requesting early refills, visiting multiple providers, or spending significant time obtaining or using the medication. A person may also become secretive about their use or continue taking pregabalin despite health, financial, work, or relationship problems.
Other warning signs can include unsuccessful attempts to reduce use, strong cravings, and prioritizing pregabalin over responsibilities or activities. Physical dependence alone does not necessarily mean a person has an addiction, so a professional assessment is important.
Pregabalin misuse can affect concentration, memory, coordination, energy, and judgment. These effects may contribute to missed work, declining performance, difficulty completing daily responsibilities, unsafe driving, or problems at school.
Continued misuse can also strain relationships as drug use becomes harder to control or conceal. Financial problems, isolation, conflict with family members, and reduced interest in usual activities can develop as substance use becomes a larger part of daily life.
A healthcare professional can assess pregabalin use by reviewing dosage patterns, prescriptions, withdrawal symptoms, tolerance, cravings, other substance use, the effects of pregabalin on daily functioning, and the patient's potential risks for misuse and dependence. The assessment may also include medical history, prior substance-use history for those at high risk, current medications, physical health, and mental health symptoms.
Clinicians can determine whether a person's symptoms meet criteria for a substance use disorder and identify co-occurring conditions that may affect treatment. Physical dependence and addiction are different, so the assessment considers the overall pattern of use rather than one symptom alone.
Pregabalin misuse is more common among people with opioid or polysubstance use, with reports increasing from 2004 to 2014. Medical sciences research and systematic review update findings in Drug Safety (Drug Saf), CNS Neuroscience & Therapeutics (CNS Neurosci Ther), and Indian Journal of Psychiatry (Ind Psychiatry) examine dependence, substance P, the “new Valium” comparison, financial support, financial constraints, Morrison MD, and misuse patterns in other countries.
Pregabalin’s rapid absorption as a gabapentinoid used for neuropathic pain and anxiety disorders may also contribute to misuse concerns.
Tolerance can develop when the body becomes accustomed to pregabalin, while regular use can lead to physical dependence. Stopping suddenly after dependence develops can cause withdrawal, so a healthcare provider may recommend gradually reducing the dose.
Symptoms may begin within a day or two after stopping and can include:
Acute withdrawal may last several days to a week, with longer symptoms depending on dose and use. Pregabalin withdrawal can cause anxiety, depression, hallucinations, and severe seizures, while benzodiazepines or venlafaxine may sometimes support treatment.
Pregabalin can increase sedation and breathing risks, especially when combined with other central nervous system depressants. Higher-risk combinations include:
Pregabalin misuse is particularly concerning when opioids or multiple substances are involved. Some people combine pregabalin with opioids to increase sedation or other drug effects, which can increase the risk of respiratory depression and overdose.
Polysubstance use may involve pregabalin alongside opioids, alcohol, benzodiazepines, stimulants, or other prescription medications. Treatment should identify all substances being used rather than addressing pregabalin alone.
Pregabalin should generally not be stopped suddenly after regular use without medical guidance. In some cases, medical detox also uses supportive medications under clinical supervision to alleviate withdrawal symptoms.
Withdrawal management may involve gradually reducing the dose, monitoring symptoms, managing complications, and treating other substance use or health conditions. The appropriate level of care depends on the person's dose, duration of use, withdrawal history, other substances used, and physical and mental health. People with severe symptoms or significant polysubstance use may require a higher level of medical support.
Pregabalin misuse can occur alongside mental health conditions, and some people may misuse the medication while trying to manage untreated symptoms; an allergic reaction is also a serious concern that may need prompt medical attention. Common co-occurring concerns can include:
Addressing substance use and mental health symptoms together can help clinicians identify triggers and develop an appropriate treatment plan.
Risk factors can include a history of substance use disorder, opioid misuse, polysubstance use, taking higher doses than prescribed, and using pregabalin without medical supervision. Untreated pain, anxiety, sleep problems, and other mental health symptoms may also contribute to patterns of misuse.
A risk factor does not mean someone will develop an addiction. Healthcare providers consider the person's overall pattern of use, health history, symptoms, and daily functioning.
Research in Drug Safety, CNS Neuroscience & Therapeutics, and Indian Journal of Psychiatry suggests a history of drug misuse may increase the risk of pregabalin misuse.
Residential treatment provides structured care in a live-in setting and may be appropriate for people with severe substance use, repeated relapse, unstable living conditions, or significant co-occurring disorders. It provides greater daily structure and separation from environments associated with substance use.
Outpatient treatment allows people to live at home while attending scheduled treatment sessions. Depending on clinical needs, care may include standard outpatient treatment, an intensive outpatient program (IOP), or a partial hospitalization program (PHP).
Help may be needed when pregabalin use becomes difficult to control, doses increase, withdrawal develops, or use affects health, work, relationships, or daily life. Severe breathing problems, seizures, loss of consciousness, or a suspected overdose require immediate emergency care.
Identifies substance use, withdrawal risks, and treatment needs.
Helps reduce and monitor withdrawal symptoms.
Provides structured live-in addiction treatment.
PHP provides intensive daytime treatment without an overnight stay.
IOP provides structured treatment several days per week.
Offers flexible therapy and ongoing support.
Helps change behaviors and thought patterns linked to substance use.
Dual Diagnosis Treatment addresses addiction and mental health disorders together.
Builds skills for managing cravings and triggers.
Many insurance plans provide benefits for substance use and mental health treatment. Coverage may include assessments, withdrawal management, residential care, PHP, IOP, outpatient therapy, and mental health services, depending on the plan and medical necessity.
Pregabalin misuse can lead to drug dependence, physical withdrawal symptoms, and pregabalin withdrawal, especially among patients with a prior history of substance abuse or drug addiction. Current evidence and systematic review findings continue to examine Lyrica addiction, the exact mechanism, dose range, drug interactions, dopamine release, excitatory neurotransmitters, and deaths linked to abuse of pregabalin.
A psychiatric assessment can also identify anxiety symptoms, panic attacks, difficulty sleeping, suicidal thoughts, and other concerns linked to psychoactive drugs and CNS drugs. Further research is needed to address misuse related unanswered questions and improve treatment for patients, especially those with opioid dependence or polysubstance use.
At New Hope Healthcare, as an in-network proccvider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial.
Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being.
Effective medication management is a crucial part of the treatment process to ensure safety and success.
Give us a call at 866-799-0806.
Yes. Pregabalin misuse can lead to tolerance, physical dependence, withdrawal, and problematic patterns of use, especially when taken differently than prescribed.
Signs may include taking larger doses, using pregabalin without a prescription, seeking early refills, cravings, sedation, and continuing use despite problems.
Stopping pregabalin after regular use can cause withdrawal symptoms. Medical guidance may help reduce withdrawal risks and manage symptoms safely.
Some people misuse pregabalin for its calming, sedating, or euphoric effects or combine it with other substances to change their effects.
Yes. Combining pregabalin with opioids, alcohol, or other central nervous system depressants can increase sedation and breathing-related risks.
Treatment may include medical assessment, withdrawal management, behavioral therapy, relapse prevention, and treatment for co-occurring substance use or mental health disorders.
In This Article
Tags
Learn how cannabis use disorder treatment can address cravings, withdrawal, sleep, anxiety, and problems affecting work or school through personalized care now.
Learn why treatment after opioid overdose matters, including rapid MAT evaluation, naloxone, counseling, family safety planning, and continued recovery support.
Autism and addiction can affect autistic people.
Learn how prescription drug misuse treatment can address medication dependence after surgery or chronic pain with one assessment, therapy, and coordinated care.
Learn how older adult alcohol misuse affects health, medications, fall risk, and daily life, plus warning signs and when outpatient treatment may offer support.
Learn how opioid use disorder and hepatitis C are connected, why testing matters, and how MAT, counseling, and medical referrals can support long-term recovery.
New Hope Healthcare Institute offers confidential admissions support for addiction and mental health care—adults and teens—in Knoxville. Call or text 24/7. Verification is not a guarantee of coverage or admission.
